GlobeNewsWire
30 Sept 2026, 12:45 UTC · 22h ago
Verdict
Headline takes no side. We score AVAI +0.80 across two claims — strongly bullish.
+0.80strongly bullish
More positive than 89% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish · 2 new · 0 priced in
Avaí Bio and Austrianova successfully encapsulated GMP-quality Klotho-producing cells using the Cell-in-a-Box platform and confirmed robust protein secretion.
Newpress release dated Sept 30, 2026
More positive than 93% of claims this week
The joint venture, Klothonova, has completed viral and adventitious agent testing of its GMP Master Cell Bank and established a Working Cell Bank.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
So whatEstablishing the WCB reduces the risk of batch-to-batch variability for any clinical trials planned for 2027.
More positive than 67% of claims this week
Which stocks this story touches
More positive than 89% of ticker scores this week
The company achieved a significant technical milestone in the development of its Klotho cell therapy program.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Globe News Wire
1h ago
+3.3%
Price agrees with the score
$0.1300 vs $0.1259 close before publication (Sep 29) · not market-adjusted
AVAI chart →
